License Agreement and Asset Acquisition (Tables)

9 Months Ended

Sep. 30, 2025

Asset Acquisition [Abstract]

Schedule of Asset Acquisition

The total consideration paid and the allocation to assets acquired and liabilities assumed was (in thousands):

Consideration
Cash consideration to acquire Chimerix’s outstanding common stock	$	802,023
Cash consideration for Chimerix’s outstanding equity awards	142,131
Total cash consideration paid to Chimerix	944,154
Transaction costs	13,237
Total consideration	$	957,391
Assets Acquired and Liabilities Assumed
Cash	$	99,338
In-process research and development	905,362
Accrued liabilities	(53,066)
Other assets and liabilities	5,757
Total net assets acquired	$	957,391